Funding for this research was provided by:
Vetenskapsrådet (VR2017-00946)
ALF agreement (ALFGBG-718711)
Hjärt-Lungfonden
Hjärnfonden
Stiftelsen Promobilia
STROKE-Riksförbundet
Article History
Received: 8 January 2020
Accepted: 24 June 2020
First Online: 1 July 2020
Ethics approval and consent to participate
: The SALGOT study and the follow-up postal survey were approved by the Regional Ethical Review Board in Gothenburg (Dnr 225–08, T801–10 and Dnr 400–13) and followed the Helsinki declaration. The data in the present study is anonymized and non-identifiable.No written or verbal consent were obtained, but information was given about the purpose of the follow-up postal survey and that participation and response to the survey was voluntary. Participants could choose to answer all or some of the questions.The Swedish Data Inspection Board has decided that data handeling within the frame of national quality registers is an exception from the general rule of informed consent because it provides improved quality of care and treatment that is of general interest. Further, for clinical puproses and quality control, no informed consent is needed to collect data from medical charts, according to Swedish law on personal particulars data (personuppgiftslagen, Swedish law No. SFS 1998:204).
: Not applicable.
: The authors declare that they have no competing interests.